https://www.selleckchem.com/pr....oducts/Rapamycin.htm
atients who have undergone pelvic RT, especially young patients. Prostate cancer (PCa) is one of the most common cancers and the fifth leading cause of cancer-related death in men. Immune responses in the tumor microenvironment are hypothesized to be related to the prognosis of PCa patients; however, no studies are available to confirm the same. In this study, we aimed to explore the potential link between these two factors and identify new biomarkers to estimate the survival rate of PCa patients. A total of 490 cases were obtained fr
Like
Comment
Share
